chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative: 70yo male patient died while on vacation on 1/12/2022. No  information given about cause of pt's death. Pt had received covid vaccines from  pharmacy on 1/23/21, 2/13/21, & 8/19/21. Likely pt's death is not related  to covid vaccines given pt's advanced age, comorbidies, and long length of time  between death & date of vaccine administrations. Past Medical History:  Hyperkalemia RA - Rheumatoid Arthritis   Allergic rhinitis Chronic kidney disease stage 2 Complaining of erectile dysfunction Benign hypertension  Hyperlipidemia Overactive bladder Benign prostatic hypertrophy without outGastroesophageal reflux  disease Anemia  Bilateral carotid artery  stenosis  Thoracic aortic aneurysm without  ruptureChronic low back pain
I had a very sore throat, and unusual sneeze and a cough. I also had congestion and body aches.
Shingles. Active for about 1 month.  Acyclovir 3/day x 7 days, prednisone, Augmentin 2/day x 10 days.  Headache, earache, jaw pain, scalp pain, lesions from top of head to chin on left side of face, general fatigue
Body aches, nausea, diarrhea within 24 hours of receiving  flu vaccine At home, taking ibuprofen, staying hydrated
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 01/19/21Lot#EL0142 2nd dose 12/29/20lot#EL3247 Diagnosed covid positive:08/06/21 Symptom onset:08/03/21 Exposure:work Symptoms:fever, cough, fatigue, muscle aches,chills, runny nose.
blacked out, passed out; could not move any part of the body; hard time breathing; sweating; A spontaneous report was received regarding a 73-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sweating, blacking out, passing out, inability to move any part of his body.  The patient's medical history was not provided. Concomitant medications were not provided.   On 01 Feb 2021, prior to the onset of the events, the patient received one of two planned doses of mRNA-1273 (Lot number: 007M20A) intramuscularly for prophylaxis of COVID-19 infection.  The injection took place in his car in a drive-in vaccination location.  On 01 Feb 2021, approximately four minutes after the mRNA-1273 vaccine was given, the patient experienced sweating, blacking out, passing out, inability to move any part of his body.   The patient reports that when he woke up he was out of his car on the grass and the emergency crew was working on him. They had given him a shot of an Epi-Pen. He had a hard time breathing and could not move any part of his body. He was placed in a wheelchair and taken into the emergency room. There, an EKG was done which had normal results. He was released from the emergency room approximately two hours later.   Action taken with mRNA-1273 was not reported.  The outcome of the events, sweating, blacking out, passing out, inability to move any part of his body, was considered resolved on 01 Feb 2021.; Reporter's Comments: Based on the current available information which indicates a strong temporal association between the use of the product and the onset of the reported events a causal relationship cannot be excluded
COPD; Bronchitis; sick; feeling really bad; Swollen glands; Cough; lots of sputum; spitting up; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A 77-years-old male patient received first dose of bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: R8737, Expiration date: Unknown), via an unspecified route of administration, in Right Arm on 04Apr2021 (at the age of 77-years-old) as dose 1, single for Covid-19 immunization. The patient medical history included Arterial sclerosis, Atrial fibrillation, Pacemaker, two heart attacks, one way bypass all from an unknown date and unknown if ongoing, 5way bypass Done at Hospital from 1986 to an unknown date, walking pneumonia from Dec1969 to an unknown date Hospitalized. There patient concomitant medications were not reported. It was reported that the patient tried calling last Tuesday when he was really sick but the waiting was beyond him. On 04Apr2021 he got the shot and it was uneventful and he was just getting finished with a slight cough and he was basically done with it, he has COPD. 05Apr2021 he started feeling really bad, spitting up, coughing, lots of sputum, he could not sleep. he went to his doctor on 06Apr2021 and was given azithromycin and took that for 5 days and is in the last throws of bronchitis, he was just about done with it and totally cleared up. he takes care of his immune system. he has tremendous swollen glands by his carotid arteries and on the side of his neck under his chin. his mother died from Hodgkin disease and she woke up one morning and had very swollen glands and then got diagnosed with it. He was afraid he has cancer and it has been awakened from the vaccine. He was afraid that something that was dormant has been awaken, he wanted to know can the vaccine do that. The swollen glands are bulging. The patient never had a fever. The patient underwent lab tests and procedures which included blood count: looked great. The outcome for the events cough, lots of sputum, swollen glands was reported as not resolved and for remaining events outcome was reported as unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Administration of Vaccine to an Underage Patient; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administration of Vaccine to an Underage Patient) in a 12-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jun-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administration of Vaccine to an Underage Patient). On 12-Jun-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administration of Vaccine to an Underage Patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information was provided by the reporter.
This is not a report for an adverse event, but more of a vaccination error due to lack of proper documentation of a previous vaccine. My son was given a 3rd shot of the primary series of covid. He is not a high risk patient. He was given this shot due to the clinic failing to properly document the 1st vaccine my son received on December 10, 2021 in the local tracing system. Additionally, local health services did not inform me that the location they scheduled my son for his first two shots was a different facility and the electronic health record systems do not "talk" to each other from our normal facility to the facility where he received shots. It is extremely misleading and deceiving as to if the clinics are of the same company, yet there is a difference and causes a lack of communication at the provider and patient level.
Red eye; Eyes like purple; Cant stop poops; Lumps inside starting performing; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR HYPERAEMIA (Red eye), EYE COLOUR CHANGE (Eyes like purple), DIARRHOEA (Cant stop poops) and SWELLING (Lumps inside starting performing) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced OCULAR HYPERAEMIA (Red eye), EYE COLOUR CHANGE (Eyes like purple), DIARRHOEA (Cant stop poops) and SWELLING (Lumps inside starting performing). At the time of the report, OCULAR HYPERAEMIA (Red eye), EYE COLOUR CHANGE (Eyes like purple), DIARRHOEA (Cant stop poops) and SWELLING (Lumps inside starting performing) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No Concomitant medication were reported.  No treatment medication were reported.    This case was linked to MOD-2021-024688 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Follow up information received on 13-MAY-2021, Significant Follow up appended On 13-May-2021: Follow up information received on 13-MAY-2021, Non significant follow up appended; Sender's Comments:
COVID arm started about 8 days after vaccination. The red rash is still present with very mild itching.
The pt experienced soreness to the left arm for several weeks, then soreness with deep pain. The pt experienced numbness in Index and thumb. Was seen by a doctor on 2/27/01 and one more time since. Pain medication provided no relief. Placed on steroids with little relief. Appointment on 4/23/01.
R back rash starting about the size of a soft ball and has spread to entire back with redness, itching, and hives.
When she awoke 1/10, her arm was very painful. She checked her blood pressure and it was 196/91. It continued to stay in that range until she went to ED on 1/15. They increased hydralazine to 25 mg twice daily and added amlodipine 10 mg daily.
soar throat; stomach pain; cold; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (soar throat), ABDOMINAL PAIN UPPER (stomach pain), NASOPHARYNGITIS (cold), HEADACHE (headache) and CHILLS (chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (soar throat), ABDOMINAL PAIN UPPER (stomach pain), NASOPHARYNGITIS (cold), HEADACHE (headache) and CHILLS (chills). At the time of the report, OROPHARYNGEAL PAIN (soar throat), ABDOMINAL PAIN UPPER (stomach pain), NASOPHARYNGITIS (cold), HEADACHE (headache) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Mom stated patient sat down in waiting room (after vaccine administered) patient stated she did not feel well; once she sat down mom stated her body tensed up and patients head rolled back. -lasting roughly a minute.
Patient stated she felt weird and had tingling on her upper lip and neck area. Her blood pressure and pulse were elevated. Patient also had red blotches on her chest when EMS arrived.
Extreme muscle weakness in lower extremities. Currently using a walker when previously never had a gait issue. Developed Bell?s palsy.  Weakness and at times severe pain in shoulders and arms. Tingling sensations in hands.  Decreased feeling in legs and feet.  These weaknesses are bilateral. Started with general feeling ?off? approx April 1, progressed to severe back pain April 13, visit to ER April 16 diagnosed with pneumonia sent home with antibiotics.  Back to ER April 21 with severe back pain and beginning to have difficulty walking and weakness. Sent home with naproxen and muscle relaxers. Back to ER on April 24 fearing a stroke due to face droop.  Admitted. Several tests run to R/O stroke,myasthenia gravis, lymes disease.  Diagnosed with Bell?s palsy. Sent home on April 28. Still extremely weak. Using a walker. Still in pain. Sent back to ER per physician for another brain MRI on may 4. Not done due to argument between ER staff and physician who sent him in.
mini-flu; body aches; headache; chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (mini-flu), MYALGIA (body aches), HEADACHE (headache) and CHILLS (chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (mini-flu), MYALGIA (body aches), HEADACHE (headache) and CHILLS (chills). At the time of the report, INFLUENZA (mini-flu), MYALGIA (body aches), HEADACHE (headache) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment reported.
The day after I received dose 4 my left was beginning to feel sore. I could move my arm in general but sharp pain would shoot all the way from my neck all the way down my arm. I went to the doctor and was told that the muscle was aggravated. It is so painful I have to bend over. The doctor also said they may have hit a vein or blood vessel. The pain has not gotten worse, but it has not improved. I was taking TYLENOL but the doctor also prescribed oxycodone.
Information has been received from a nurse referring to an unspecified number of patients with unknown age and gender. On unknown dates in 2015 ("since 16-APR-2015") the patients were vaccinated with doses of M-M-R II (lot # K002528, expiration date 18-FEB-2016; lot # K005175, expiration date 10-APR-2016) (dose and route were not reported), which were exposed to temperatures outside of the recommended range. No adverse experience had been reported. This is one of several reports received from the same reporter. Additional information has been requested.
ACHES, PAINS; HIGH FEVER; NAUSEA; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 28-MAR-2021 12:00 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, Laboratory data included: Body temperature (NR: not provided) between 100.8° and 102°. On 28-MAR-2021, the subject experienced aches, pains. On 28-MAR-2021, the subject experienced high fever. On 28-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the high fever, aches, pains and nausea was not reported. This report was non-serious.
high fever of 99.9; arm pain; nausea; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) report that a 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 30Jun2021 (at the age of 66 years old) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 30Jun2021, the patient stated that in about five to ten minutes, she experienced a high fever of 99.9 and also had arm pain and she also experienced nausea after the first dose. She stated the arm pain and nausea came after, that the fever spiked right away and she didn't think it was 10 minutes, stated she may have had it before. The patient came in after the vaccine and it was 99.9, they gave her the vaccine, walked out and came in a little later and gave her the scan temperature to her head. She was wondering if she should get the second one. She stated that her doctor didn't really know he has other ways of dealing with the virus and she didn't know who to ask. The patient was asking how protected is she after the first dose. The outcome of the events was unknown.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Generalized edema over entire rt maxilla & mandible beginning 24AUG91, w/nausea, pruritis of hands x 1 day beginning 27AUG91; tender enlarged firm rt submaxillary node to 1.5cm w/o discoloration; nose w/generalized edema of mucous membranes
Extreme back pain. I first felt a strange sensation in my back.  It felt like, starting in my mid-back and going down to my lower-back, someone was slowly pulling a shade down - it was a sensation of movement. Then the extreme back pain started. It was intermittent (on and off) for about 5 to 10 minutes total.  While the pain was on, I could not walk or function.  It was the worst pain I have ever felt. I would rate it "10" out of "10."  Additionally, my right shoulder was  sore for at least 3 weeks, and even now - 2 months later - it still feels a little sore on certain movements.
Following vax, the pt felt nauseated, sick, and was in excruciating pain, both headaches and neck / shoulder pain. (Pt had shoulder pain and headache the day she received the vax). She experienced vision/head felt foggy. She was treated for torn ligaments and soft tissue damage in upper back/neck. She then experienced double vision and distorted vision unless one or the other eye was closed. A neurologist was 80% sure she had Lyme Meningitis. Was treated with Rocephin. The pt still experienced nerve/muscle damage in the right eye, pain in feet, knees, hips, right elbow, shoulders, fingers, headaches, fatigue, shortness of breath, sensitivity to bright sunlight, neck pain. Spouse notices some loss of thought process.
within 5 minutes of receiving the vaccine patient became light headed, cold clammy skin with cold sweats, blurry vision, dizzy, pale/gray skin, and short of breath. Pulse was 60 and BP 90/60- epinephrine 0.5 mg given, pt BP 80/60 returned to 129/88. EMS evaluated patient- patient declined to go with EMS to ER or to go to the ER- pt stated 1 hour after onset that he felt fine and declined to go to ER eventhough he was advised to but states that he will go if he feels he needs to but that he feels normal now.
THE SAME EVENING AFTER RECEIVING THE VACCINATION, PATIENT NOTICED RED RASH COVERING AREA WHERE VACCINES WERE GIVEN. THE FOLLOWING DAY, PATIENT NOT NOTICED A QUARTER SIZE BRUISE WITHIN THE RED AREA. RED AREA IS WARM TO TOUCH. PATIENT REPORTED ARM BEING EXTREMELY SORE THE FIRST NIGHT AND SORENESS HAS BEEN RESOLVED. RED AREA AND BRUISE ARE STILL WARM TO TOUCH FOUR DAYS LATER.
Anxiety; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of ANXIETY (Anxiety) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANXIETY (Anxiety). At the time of the report, ANXIETY (Anxiety) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter was a pharmacist who was reporting on behalf of their patient who received their vaccine dose and had anxiety for at least a month. Reportedly, the anxiety been ongoing.   No Concomitant product use was reported. No treatment information was provided.
The morning after the injection I have low grade fever (99.4), chills, body aches, stomach ache, and head ache.
My supraclavicular lymph nodes swelled to the size of grapes.  Still swollen. Haven't been to dr
rph administered Pfizer vaccine in Right Deltoid muscle and the site of injection immediately swelled up and patient experienced syncope and laid on the floor. Patient was clamy and had ringing in the ears but resolved after 10 minutes. Nodule seemed to go down a little and did not need to administer any medication. Observed for 30 minutes before leaving. Advised her to consult her PCP on Monday for any further suggestions for subsequent vaccines and to seek help/treatment if anything persists or gets worst.
approx 3yrs p/vax pt lab tests revealed pt had failed to seroconvert
Severe chest pain - went to ER. EKG irregular and high levels of troponin found. Doctors believe vasospasms is what is occuring. Currently taking verapamil daily for the spasms and nitroglycerin for the pain as needed
Patient received meningococcal vaccine at 9:30AM pt appeared fine, walked down hallway to check out, sat down in chair. Mom noticed child is pale and he then slid off chair. No LOC. P-76 B/P-114/70 - seen by MD. Blood sugar-104 - pt observed and discharged at 10:30AM.
Initial case received on 23 October 2014 from a healthcare professional. Three unidentified adult patients, both male and female were vaccinated intramuscularly into the left deltoid with ADACEL, (batch number U4874AA). One was vaccinated in August 2014, one in September 2014 and one in October 2014. The first patient returned to the office three days later and was treated with Clindamycin. The other two patients phoned to report arm swelling, soreness and pain on an unspecified date. Follow-up with the patients was not done. The patients' concomitant medications and medical history were not reported. Laboratory tests were not reported, The patient outcomes are unknown. Documents held by sender: None.
arm soreness; fever; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), PYREXIA (fever) and MYALGIA (muscle aches) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm soreness), PYREXIA (fever) and MYALGIA (muscle aches). At the time of the report, PAIN IN EXTREMITY (arm soreness) outcome was unknown and PYREXIA (fever) and MYALGIA (muscle aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (Inconclusive) 102 degree Celsius.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information in response to events was not provided.
the pain in my shoulder and upper arms never went away; the pain in my shoulder and upper arms never went away; can't hardly raise my arms up specially my right arm that I got 2 or 3 shots; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHRALGIA (non-serious), PAIN IN EXTREMITY (non-serious), outcome "not recovered" and all described as "the pain in my shoulder and upper arms never went away"; INJECTED LIMB MOBILITY DECREASED (non-serious), outcome "not recovered", described as "can't hardly raise my arms up specially my right arm that I got 2 or 3 shots".  Additional information: Ever since the patient got Covid shots the pain in shoulder and upper arms never went away. Now after a few years it got even worse. The patient used to do 50-100 push ups a day. Patient can't hardly raise arms up specially right arm that got 2 or 3 shots. Patient cannot handle this pain any more after 2 and half years. The patient was a strong healthy person and seldom like to go to a doctor.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.